Skip to main content
Clinical Trials/NCT05274464
NCT05274464CompletedNot Applicable

A Recurrence Nomogram to Guide Surveillance Strategies After the Resection of Hepatoid Adenocarcinoma of the Stomach: a China Hepatoid Adenocarcinoma of the Stomach Study Group Database Study

Fujian Medical University1 site in 1 country261 target enrollmentStarted: April 1, 2004Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
261
Locations
1
Primary Endpoint
Reurrence-free survival

Study Overview

Brief Summary

This study aims to develop a nomogram to predict postoperative recurrence of HAS and guide individually tailored surveillance strategies.

Detailed Description

Patients were included from the China Hepatoid Adenocarcinoma of the Stomach Study Group (China-HASSG) database, which comprises 14 tertiary referral centers. All the patients who had undergone complete resection of a primary HAS between April 2004 and December 2019 were included. First, univariate analysis was performed in Cox regression to identify the risk factors associated with RFS. Next, variables with P< 0.05 in univariable analysis were included in the multivariable model, and the forward likelihood ratio method was used for analysis to confirm the independent prognostic factors associated with RFS. Finally, based on the results of multivariable analysis, variables that achieved significance at P< 0.05 were selected to formulate a nomogram.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients who had undergone complete resection of a primary HAS between April 2004 and December 2019

Exclusion Criteria

  • Patients with metastatic disease, patients who had undergone palliative surgery, patients who had died within 30 days, and patients who were lost to follow-up

Outcomes

Primary Outcomes

Reurrence-free survival

Time Frame: 3 year

Reurrence-free survival was defined as the time interval from the date of the operation to the date of first recurrence or death from any cause.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Fujian Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Chang-Ming Huang, Prof.

Professor

Fujian Medical University

Study Sites (1)

Loading locations...

Similar Trials

A Recurrence Nomogram for Hepatoid... | Clinical Trial